BD blog

Flow cytometry is an essential technique at the heart of the life sciences, enabling researchers to identify and analyze cells to better understand human health, disease and treatment. Since...

By Arun Nair, PhD, Director, Specimen Management R&D, BD

You remember old tube TVs. Adjusting those rabbit ear antennas to remove static, banging the side of the box to make the “snow” fade. While we accepted this technology at the time, in...

Recent data show that inadequate antimicrobial treatment is more common among COVID-19 positive patients – leading to prolonged hospital stays. By Kalvin Yu, MD, FIDSA, Vice President of U.S....

By Beth McCombs, EVP and CTO

Sepsis, severe sepsis and renal insufficiency/failure rate as top three conditions associated with COVID-19 hospital mortality complications By Kalvin Yu, MD, FIDSA, Vice President of U.S. Medical...

By Jennifer Farrington, Senior Director of BD Social Investing and Vice President of the BD Foundation and Sarah Hill, Director of BD Sustainability Did you know that today, 2.1 billion people...

At BD, we’re fortunate to work alongside some of the best and brightest in med tech. We’re thrilled that two of our outstanding associates will be recognized for their leadership in the...

By Ellen Rafferty, Senior Manager, Social Investing

By Kalvin Yu, MD, FIDSA, Vice President, U.S. Medical Affairs, BD, and Tony Ezell, President, North America & Chief Marketing Officer, BD As we grapple with the challenges of the ongoing COVID-19...